The DOI matches its Crossref record; 60 of the 66 references it cites were found in a registry or an index.
Bone morphogenetic protein (BMP) for fracture healing in adults
Open accessAbstract
BACKGROUND: Delay in fracture healing is a complex clinical and economic issue for patients and health services. OBJECTIVES: To assess the incremental effectiveness and costs of bone morphogenetic protein (BMP) on fracture healing in acute fractures and nonunions compared with standards of care. SEARCH STRATEGY: We searched The Cochrane Library (2008, Issue 4), MEDLINE, and other major health and health economics databases (to October 2008). SELECTION CRITERIA: Randomised controlled trials (RCTs) and full or partial economic evaluations of BMP for fracture healing in skeletally mature adults. DATA COLLECTION AND ANALYSIS: All clinical and economic data were extracted by one author and checked by another. MAIN RESULTS: Eleven RCTs, all at high risk of bias, and four economic evaluations were included. Apart from one study, the times to fracture healing were comparable between the BMP and control groups. There was some evidence for increased healing rates, without requiring a secondary procedure, of BMP compared with usual care control in acute, mainly open, tibial fractures (risk ratio (RR) 1.19, 95% CI 0.99 to 1.43). The pooled RR for achieving union for nonunited fractures was 1.02 (95% CI 0.90 to 1.15). One study found no difference in union for patients who had corrective osteotomy for radial malunions. Data from three RCTs indicated that fewer secondary procedures were required for acute fracture patients treated with BMP versus controls (RR 0.65, 95% CI 0.50 to 0.83). Adverse events experienced were infection, hardware failure, pain, donor site morbidity, heterotopic bone formation and immunogenic reactions. The evidence on costs for BMP-2 for acute open tibia fractures is from one large RCT. This indicates that the direct medical costs associated with BMP would generally be higher than treatment with standard care, but this cost difference may decrease as fracture severity increases. Limited evidence suggests that the direct medical costs associated with BMP could be offset by faster healing and reduced time off work for patients with the most severe open tibia fractures. AUTHORS' CONCLUSIONS: This review highlights a paucity of data on the use of BMP in fracture healing as well as considerable industry involvement in currently available evidence. There is limited evidence to suggest that BMP may be more effective than controls for acute tibial fracture healing, however, the use of BMP for treating nonunion remains unclear. The limited available economic evidence indicates that BMP treatment for acute open tibial fractures may be more favourable economically when used in patients with the most severe fractures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A Cochrane review on the effects of intraoperative application of BMP on fracture healing concluded that there is limited evidence that BMP is more effective than control treatment, and the efficacy of BMP for the treatment of nonunion remains unclear (103).”
From Methods to accelerate fracture healing – a narrative review from a clinical perspective (2024) · cites this paper as [103]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A Cochrane review on the effects of intraoperative application of BMP on fracture healing concluded that there is limited evidence that BMP is more effective than control treatment, and the efficacy of BMP for the treatment of nonunion remains unclear (103).”
From Methods to accelerate fracture healing – a narrative review from a clinical perspective (2024) · cites this paper as [103]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
(2008) · Cited by 3,790
Assessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147
Guidelines for authors and peer reviewers of economic submissions to the BMJ
Drummond, M. F., & Jefferson, T. O. (1996) · BMJ · doi:10.1136/bmj.313.7052.275 · Cited by 1,827
Complications of Iliac Crest Bone Graft Harvesting
Arrington, E. D., Smith, W. J., Chambers, H. G., Bucknell, A. L., & Davino, N. A. (1996) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199608000-00037 · Cited by 1,548
Epidoxorubicin In, A., Cascinu, S., Labianca, R., Barone, C., Santoro, O., Carnaghi, C., Frontini, L., Aitini, E., Rota, S., Torri, V., et al. (2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_6514 · Cited by 1,394
GOVENDER, S., CSIMMA, C., GENANT, H. K., & VALENTIN-OPRAN, A. (2002) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200212000-00001 · Cited by 1,308
Iliac Crest Bone Graft Harvest Donor Site Morbidity
Banwart, J. C., Asher, M. A., & HASSANEIN, R. S. (1995) · Spine · doi:10.1097/00007632-199505000-00012 · Cited by 1,281
Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions
Friedlaender, G. E., Perry, C. R., Cole, J. D., Cook, S. D., Cierný, G., Muschler, G. F., Zych, G. A., Calhoun, J. H., LaForte, A. J., & Yin, S. (2001) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-200100002-00010 · Cited by 956
Research works printed but not linked: 12
- Jones AL Swiontkowski MF Polly DW Duff SB Ackerman SJ Use of rhBMP-2 in the treatment of open tibial shaft fractures: Do improved clinical outcomes outweigh the additional expense of rhBMP-2 [poster] Proceedings of the 20th Annual Meeting of the Orthopaedic Trauma Association; 2004 Oct 8-10; Hollywood (FL). Available from www.hwbf.org/ota/am/ota04/otapo/OTP04015.htm
- McKee MD Schemitsch EH Waddell JP Kreder HJ Stephen DJG Leighton RK The effect of human recombinant bone morphogenic protein (rhBMP-7) on the healing of open tibial shaft fractures: results of a multi-center, prospective, randomized clinical trial [abstract] Proceedings of the 18th Annual Meeting of the Orthopaedic Trauma Association; 2002 Oct 11-13; Toronto (ON). Available from www.hwbf.org/ota/am/ota02/otapa/OTA02745.htm
- Perry CR Cole D Perry M Cierny G Osteogenic protein (OP-1) vs autograft in the management of tibial non-unions [poster] Proceedings of the 13th Annual Meeting of the Orthopaedic Trauma Association; 1997 Oct 17-19; Louisville (KY). Available from www.hwbf.org/ota/am/ota97/otapo/OTP97064.htm
- Xiao, 2007, Bone morphogenetic protein vs iliac bone graft substitute with internal fixation in the treatment of osteoporotic intertrochanteric fracture, Journal of Clinical Rehabilitative Tissue Engineering Research, 11, 4077
- Swiontkowski, 2006, Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies, Journal of Bone & Joint Surgery - American Volume, 88, 1258
- Craig, 2007, CRD Report 6: NHS Economic Evaluation Database Handbook (3rd Edition), 1
- Dahabreh, 2007, Health economics: a cost analysis of treatment of persistent fracture non-unions using bone morphogenetic protein-7, Injury, 38, 371, 10.1016/j.injury.2006.08.055 · DOI
- Friedlaender, 2001, Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions, The Journal of Bone & Joint Surgery - American Volume, 83-A Suppl 1, S151
- Jones, 2006, Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial, Journal of Bone & Joint Surgery - American Volume, 88, 1431
- Kanakaris, 2007, The health economics of the treatment of long-bone non-unions, Injury, 38, S77, 10.1016/S0020-1383(07)80012-X · DOI
- Swiontkowski, 2006, Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies, Journal of Bone & Joint Surgery - American Volume, 88, 1258
- Garrison, 2007, Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review, Health Technology Assessment, 11, 1-150. Availabl, 10.3310/hta11300 · DOI
Cited by
Sorted by citations
TGF-β and BMP Signaling in Osteoblast Differentiation and Bone Formation
Chen, G., Deng, C., & Li, Y.-P. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.2929 · Cited by 1,756
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
Bone fracture healing in mechanobiological modeling: A review of principles and methods
Ghiasi, M. S., Chen, J. C., Vaziri, A., Rodriguez, E. K., & Nazarian, A. (2017) · Bone Reports · doi:10.1016/j.bonr.2017.03.002 · Cited by 486
Treatment of critical-sized bone defects: clinical and tissue engineering perspectives
Roddy, E., DeBaun, M. R., Daoud-Gray, A., Yang, Y., & Gardner, M. J. (2017) · European Journal of Orthopaedic Surgery & Traumatology · doi:10.1007/s00590-017-2063-0 · Cited by 463
Bone fracture healing: Cell therapy in delayed unions and nonunions
Gómez‐Barrena, E., Rosset, P., Lozano, D., Stanovici, J., Ermthaller, C., & Gerbhard, F. (2014) · Bone · doi:10.1016/j.bone.2014.07.033 · Cited by 423
Metadata
- Authors
- Garrison, K. R., Shemilt, I., Donell, S., Ryder, J. J., Mugford, M., Harvey, I., Song, F., & Alt, V.
- Affiliations
- University of East Anglia (GB)
- Universitätsklinikum Gießen und Marburg (DE)
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2010-06-16
- Volume
- 2010
- Issue
- 6
- Pages
- CD006950-CD006950
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- PMC
- PMC6669254
- OpenAlex
- W2147144859
- Cited by
- 278
- References
- 66
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 10 · 2023: 13 · 2022: 9 · 2021: 23 · 2020: 18 · 2019: 21 · 2018: 18 · 2017: 18 · 2016: 21 · 2015: 18 · 2014: 32 · 2013: 30 · 2012: 20
- FWCI
- 2.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- National Institute for Health and Care Research (04/34/02)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone fractures and treatments
- Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- bone morphogenetic proteins, fracture healing, nonunion, acute fractures, tibial fractures, open fractures, corrective osteotomy, secondary procedures, heterotopic ossification, donor site morbidity, health care costs, economic evaluation, time to union, hardware failure, infection risk
- MeSH terms
- Adult, Cost-Benefit Analysis, Fractures, Ununited, Humans, Radius Fractures, Recombinant Proteins, Tibial Fractures, Randomized Controlled Trials as Topic, Transforming Growth Factor beta, Health Care Costs, Fracture Healing, Fractures, Malunited, Bone Morphogenetic Proteins, Fractures, Bone, Bone Morphogenetic Protein 2, Bone Morphogenetic Protein 7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
